Your Guide to Personalised Healthcare

Learn from the AttoDiagnostics blog.

Pharmacogenomic Testing for Bipolar Disorder

Published 17/09/2024

Bipolar Disorder (BP) is a mental health disorder that affects an individual’s moods causing them to have episodes or periods of extreme mood swings with symptoms of depression and/or mania.These mood swings can make it challenging for individuals to lead a normal life and perform everyday tasks

Using Pharmacogenomics (PGx) to Choose the Best Medication for ADHD

Published 11/09/2024

Choosing the best medication for ADHD (Attention- Deficit /Hyperactivity Disorder) can be a challenging task and careful evaluation of various factors such as the patient’s characteristics, side effects that could potentially arise and their response to any previous treatment is needed.

The Role of Genetics in Anticonvulsant and Antipsychotic Treatment

Published 23/08/2024

Anticonvulsants and antipsychotics are crucial medications used to manage conditions such as epilepsy, bipolar disorder, and schizophrenia. However, like many medications, their effectiveness and side effect profiles can vary widely from person to person.

The Role of Genetics in Citalopram and Sertraline Treatment

Published 22/08/2024

Citalopram and Sertraline are two of the most commonly prescribed antidepressants in the UK, often used to treat conditions like depression and anxiety. While these medications are effective for many people, their success can vary widely from person to person.

Understanding Common Adverse Drug Reactions (ADRs) in Mental Health Medications

Published 20/08/2024

Managing the side effects of psychotic and antipsychotic medications is a crucial aspect of patient care for GPs, Psychiatrists and Mental Health Professionals. Adverse drug reactions (ADRs) can significantly impact a patient's adherence to medication and overall quality of life, and with today's PGx testing, can be avoided.

How Ethnicity Plays a Role in Personalised Medicine

Published 19/08/2024

By understanding how an individual’s genetic makeup influences their response to medications, healthcare providers can tailor treatments to maximise effectiveness and minimise adverse effects. However, the efficacy and accuracy of these medications can vary significantly across different populations, primarily due to the differences in the availability and depth of research conducted on diverse ethnic groups.

The Role of Pharmacogenomics Testing in Antidepressant Treatment

Published 16/08/2024

In the complex world of mental health management, finding the right antidepressant can be a daunting task. What works wonders for one person might offer no relief or worse, cause significant side effects for another. However, recent advancements in pharmacogenomics offer a promising solution: personalised medicine tailored to your genetic makeup.

The Benefits of Pharmacogenomic (PGx) Testing for Psychiatric Prescriptions

Published 24/06/2024

In the realm of psychiatric care, prescribing the right medication is often a complex and challenging process. Many patients undergo a trial-and-error approach, trying different medications and dosages until an effective regimen is found. This process can be lengthy, costly, and distressing for patients and their families. At AttoDiagnostics, we believe that pharmacogenomic (PGx) testing offers a transformative solution to these challenges.

Why Methylation DNA Testing is an Interesting Alternative to Common

Published 24/06/2024

In the realm of genetic testing, methylation DNA testing has emerged as a promising alternative to traditional "health and wellness" DNA tests. Unlike conventional tests that focus on genetic predispositions, methylation testing provides insights into gene expression and the impact of environmental factors. One of the most compelling aspects of methylation testing is its ability to guide dietary modifications by identifying specific nutrient deficiencies and their effects on overall health.